Current immunotherapeutic approaches in pancreatic cancer. Sep 2011 - Clin. Dev. Immunol.; 2011:1740-2530 [PMID:21922022] [Koido S] [Homma S] [Takahara A] [Namiki Y] [Tsukinaga S] [Mitobe J] [Odahara S] [Yukawa T] [Matsudaira H] [Nagatsuma K] [Uchiyama K] [Satoh K] [Ito M] [Komita H] [Arakawa H] [Ohkusa T] [Gong J] [Tajiri H]
Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells. Apr 2010 - J. Biomed. Biotechnol.; 2010:1110-7251 [PMID:20379390] [Koido S] [Homma S] [Hara E] [Namiki Y] [Ohkusa T] [Gong J] [Tajiri H]
In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells. Oct 2008 - J Transl Med; 6:1479-5876 [PMID:18793383] [Koido S] [Homma S] [Hara E] [Mitsunaga M] [Namiki Y] [Takahara A] [Nagasaki E] [Komita H] [Sagawa Y] [Ohkusa T] [Fujise K] [Gong J] [Tajiri H]
Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Mar 2007 - Vaccine; 25(14):0264-410X [PMID:17239504] [Koido S] [Tanaka Y] [Tajiri H] [Gong J]
Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Nov 2005 - Clin. Cancer Res.; 11(21):1078-0432 [PMID:16278414] [Koido S] [Hara E] [Homma S] [Torii A] [Toyama Y] [Kawahara H] [Watanabe M] [Yanaga K] [Fujise K] [Tajiri H] [Gong J] [Toda G]
Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells. Sep 2005 - Int. J. Cancer; 117(4):0020-7136 [PMID:15945098] [Koido S] [Hara E] [Torii A] [Homma S] [Toyama Y] [Kawahara H] [Ogawa M] [Watanabe M] [Yanaga K] [Fujise K] [Gong J] [Toda G]
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Jul 2004 - Clin. Cancer Res.; 10(14):1078-0432 [PMID:15269142] [Avigan D] [Vasir B] [Gong J] [Borges V] [Wu Z] [Uhl L] [Atkins M] [Mier J] [McDermott D] [Smith T] [Giallambardo N] [Stone C] [Schadt K] [Dolgoff J] [Tetreault JC] [Villarroel M] [Kufe D]
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma. Apr 2004 - Br. J. Haematol.; 125(3):0007-1048 [PMID:15086415] [Raje N] [Hideshima T] [Davies FE] [Chauhan D] [Treon SP] [Young G] [Tai YT] [Avigan D] [Gong J] [Schlossman RL] [Richardson P] [Kufe DW] [Anderson KC]
Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Mar 2002 - Blood; 99(7):0006-4971 [PMID:11895787] [Gong J] [Koido S] [Chen D] [Tanaka Y] [Huang L] [Avigan D] [Anderson K] [Ohno T] [Kufe D]